Onghena L, van Nieuwenhove Y, Van Vlierberghe H, Devisscher L, Raevens S, Verhelst X
United European Gastroenterol J. 2024; 12(10):1440-1449.
PMID: 39545623
PMC: 11652326.
DOI: 10.1002/ueg2.12642.
Sachar M, Pan J, Park J
Gastro Hep Adv. 2024; 1(6):1006-1013.
PMID: 39131248
PMC: 11307418.
DOI: 10.1016/j.gastha.2022.06.011.
Sandoval C, Reyes C, Rosas P, Godoy K, Souza-Mello V, Farias J
Int J Mol Sci. 2023; 24(21).
PMID: 37958712
PMC: 10648767.
DOI: 10.3390/ijms242115728.
Huang G, Wallace D, Powell E, Rahman T, Clark P, Subramaniam V
Biomedicines. 2023; 11(10).
PMID: 37893185
PMC: 10604560.
DOI: 10.3390/biomedicines11102809.
Yan M, Li H, Xu S, Wu J, Li J, Xiao C
Int J Mol Sci. 2023; 24(14).
PMID: 37511074
PMC: 10379228.
DOI: 10.3390/ijms241411313.
Efficacy of 3 months of additional pioglitazone treatment in type 2 diabetes patients with alcoholic fatty liver disease.
Asakawa M, Takagi N, Hamada D, Yamasaki Y, Katsuta H
Diabetol Int. 2023; 14(3):243-251.
PMID: 37397908
PMC: 10307745.
DOI: 10.1007/s13340-023-00619-z.
Therapeutic targets in alcohol-associated liver disease: progress and challenges.
Adekunle A, Adejumo A, Singal A
Therap Adv Gastroenterol. 2023; 16:17562848231170946.
PMID: 37187673
PMC: 10176580.
DOI: 10.1177/17562848231170946.
Transcriptome changes in stages of non-alcoholic fatty liver disease.
Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H
World J Hepatol. 2022; 14(7):1382-1397.
PMID: 36158924
PMC: 9376779.
DOI: 10.4254/wjh.v14.i7.1382.
Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases.
Perramon M, Jimenez W
Int J Mol Sci. 2022; 23(13).
PMID: 35805898
PMC: 9267054.
DOI: 10.3390/ijms23136897.
Ameliorative effects of extract and main component cirsimaritin in mice model of high-fat diet-induced metabolic dysfunction-associated fatty liver disease.
Che D, Shin J, Kang H, Cho B, Park J, Wang F
Food Sci Nutr. 2021; 9(11):6060-6068.
PMID: 34760237
PMC: 8565240.
DOI: 10.1002/fsn3.2548.
Development and validation of a neural network for NAFLD diagnosis.
Sorino P, Campanella A, Bonfiglio C, Mirizzi A, Franco I, Bianco A
Sci Rep. 2021; 11(1):20240.
PMID: 34642390
PMC: 8511336.
DOI: 10.1038/s41598-021-99400-y.
Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways.
Suzuki-Kemuriyama N, Abe A, Nakane S, Uno K, Ogawa S, Watanabe A
FEBS Open Bio. 2021; 11(11):2950-2965.
PMID: 34390210
PMC: 8564345.
DOI: 10.1002/2211-5463.13272.
Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
Yin C, Li Z, Xiang Y, Peng H, Yang P, Yuan S
Front Nutr. 2021; 8:709683.
PMID: 34322514
PMC: 8310935.
DOI: 10.3389/fnut.2021.709683.
Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.
Kang K, Sun Y, Pan D, Sang L, Sun M, Li Y
Exp Ther Med. 2021; 21(5):418.
PMID: 33777186
PMC: 7967804.
DOI: 10.3892/etm.2021.9862.
Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
Sorino P, Caruso M, Misciagna G, Bonfiglio C, Campanella A, Mirizzi A
PLoS One. 2020; 15(10):e0240867.
PMID: 33079971
PMC: 7575109.
DOI: 10.1371/journal.pone.0240867.
LPCN 1144 Resolves NAFLD in Hypogonadal Males.
Albhaisi S, Kim K, Baker J, Chidambaram N, Patel M, Charlton M
Hepatol Commun. 2020; 4(10):1430-1440.
PMID: 33024914
PMC: 7527694.
DOI: 10.1002/hep4.1571.
Characterization of two types of intranuclear hepatocellular inclusions in NAFLD.
Schwertheim S, Kalsch J, Jastrow H, Schaefer C, Theurer S, Ting S
Sci Rep. 2020; 10(1):16533.
PMID: 33024131
PMC: 7538976.
DOI: 10.1038/s41598-020-71646-y.
Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis.
Banerjee A, Das D, Paul R, Roy S, Das U, Saha S
Sci Rep. 2020; 10(1):15443.
PMID: 32963259
PMC: 7508805.
DOI: 10.1038/s41598-020-72076-6.
Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver.
Lim H, Choi J, Lee B, Kim S, Kim Y, Yoo J
Clin Nutr Res. 2020; 9(3):182-194.
PMID: 32789148
PMC: 7402975.
DOI: 10.7762/cnr.2020.9.3.182.
Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation.
Asimakopoulou A, Engel K, Gassler N, Bracht T, Sitek B, Buhl E
Cells. 2020; 9(6).
PMID: 32481590
PMC: 7348929.
DOI: 10.3390/cells9061346.